Galectin Therapeutics Inc (NASDAQ:GALT)

3.40
Delayed Data
As of Feb 27
 -0.08 / -2.30%
Today’s Change
3.00
Today|||52-Week Range
18.83
-2.02%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close3.48
Today’s open3.46
Day’s range3.40 - 3.74
Volume120,322
Average volume (3 months)304,524
Market cap$75.8M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-8.45%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book69.93

Competitors

 Today’s
change
Today’s
% change
TRILTrillium Therapeutic...-0.27-1.80%
CGIXCancer Genetics Inc-0.62-6.61%
GBIMGlobeImmune Inc+0.46+6.48%
TROVUTrovagene Inc0.000.00%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account